Mahony Susan 4
4 · Axsome Therapeutics, Inc. · Filed Oct 12, 2023
Insider Transaction Report
Form 4
Mahony Susan
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-10-10+5,873→ 5,873 totalExercise: $70.56Exp: 2033-10-10→ Common Stock (5,873 underlying) - Award
Stock Option (Right to Buy)
2023-10-10+1,502→ 1,502 totalExercise: $70.56From: 2024-10-10Exp: 2033-10-10→ Common Stock (1,502 underlying)
Footnotes (2)
- [F1]The option vests in full on the one-year anniversary of the date of grant, October 10, 2024.
- [F2]The option will vest in equal annual installments over three years such that the option will be fully vested on October 10, 2026.